PTP4A3 and invasive breast carcinoma: The highest ranking hit from our screen, PTP4A3 (encoding PRL-3) (Figure 4C), was amplified or up regulated in approximately 8-16% of all invasive breast cancers between two TCGA datasets [8, 21] (Figure 4D).